Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 19;32(4):540-554.
doi: 10.1055/s-0042-1754361. eCollection 2022 Dec.

Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma

Pankaj Gupta  1 , Naveen Kalra  1 , Sreedhara B Chaluvashetty  1 , Shivanand Gamangatti  2 , Amar Mukund  3 , Razik Abdul  2 , V S Shyam  3 , Sanjay Saran Baijal  4 , Chander Mohan  5
Affiliations
Review

Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular Carcinoma

Pankaj Gupta et al. Indian J Radiol Imaging. .

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies and a significant cause of cancer-related death. Treatment of HCC depends on the stage of the tumor. As many patients with HCC are not deemed fit for surgical resection or liver transplantation, locoregional therapies play an essential role in the management. Image-guided locoregional treatments include percutaneous ablative therapies and endovascular therapies. The choice of an individual or a combination of therapies is guided by the tumor and patient characteristics. As the outcomes of image-guided locoregional treatments depend on the ability to achieve necrosis of the entire tumor along with a safety margin around it, it is mandatory to follow standard guidelines. In this manuscript, we discuss in detail the various aspects of image-guided locoregional therapies to guide interventional radiologists involved in the care of patients with HCC.

Keywords: hepatocellular carcinoma; interventional radiologists; locoregional treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Similar articles

See all similar articles

Cited by

References

    1. White D L, Thrift A P, Kanwal F, Davila J, El-Serag H B. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology. 2017;152(04):812–8.2E7. - PMC - PubMed
    1. Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol. 2021;75(01):108–119. - PubMed
    1. Heimbach J K, Kulik L M, Finn R S. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(01):358–380. - PubMed
    1. Foltz G. Image-guided percutaneous ablation of hepatic malignancies. Semin Intervent Radiol. 2014;31(02):180–186. - PMC - PubMed
    1. Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of hepatocellular carcinoma. Semin Intervent Radiol. 2013;30(01):3–11. - PMC - PubMed

Grants and funding

Funding None.